Guo-wen Yin
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
TACE plus donafenib and immune checkpoint inhibitors for intermediate HCC (CHANCE2410 study): a propensity score matching analysis.
Journal: European radiology experimental
Published: July 31, 2025
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204).
Journal: Hepatology (Baltimore, Md.)
Published: July 13, 2025
Efficacy of Atezolizumab Plus Bevacizumab Combined with Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Real-World Study.
Journal: Journal of hepatocellular carcinoma
Published: June 11, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
Journal: EClinicalMedicine
Published: January 10, 2024
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.
Journal: Hepatology international
Published: July 07, 2023
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching study.
Journal: European radiology
Published: October 05, 2022
Irradiation stent with 125 I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial.
Journal: International journal of surgery (London, England)
Published: September 05, 2022
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Journal: Signal transduction and targeted therapy
Published: June 14, 2022
Nomogram and Artificial Neural Network for Prognostic Performance on the Albumin-Bilirubin Grade for Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Journal: Journal of vascular and interventional radiology : JVIR
Published: April 02, 2018
Multicentric Assessment of the Hong Kong Liver Cancer Staging System in Chinese Patients Following Transarterial Chemoembolization.
Journal: Cardiovascular and interventional radiology
Published: March 26, 2018
Multi-target lentivirus specific to hepatocellular carcinoma: in vitro and in vivo studies.
Journal: Journal of hepatology
Published: April 11, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026